NFKB1 and neoplasm: While such a possibility would be surprising given recent reports that FGFR2 acts as a negative regulator of NFκB activity and suppresses tumor growth in UC cells [68], [69], it is consistent with our finding that FGFR2 can also interact with TAK1 (Figure 1E).